AOD-9604 Pen
AOD-9604 is a synthetic peptide fragment derived from human growth hormone (hGH, amino acids 176–191), developed specifically for research into fat metabolism and lipolysis without the growth-promoting effects associated with full-length hGH.
Supplied in a sterile peptide pen, AOD-9604 has been widely studied for its ability to stimulate fat breakdown while inhibiting lipogenesis, making it a valuable compound for body composition, metabolic regulation, and adipose tissue research.
Key Features
🔥 hGH-derived peptide (176–191 fragment)
💉 Sterile peptide pen format for accurate research dosing
🧪 High-purity, research-grade formulation
⚙️ Targets lipolysis without GH-related growth activity
📄 For laboratory research use only
Key Benefits (Research-Based)
🔥 Stimulates Fat Breakdown (Lipolysis)
• Activates pathways involved in releasing stored fat from adipose tissue
🚫 Inhibits Fat Storage (Lipogenesis)
• Studied for its ability to reduce new fat accumulation
⚡ Supports Metabolic Efficiency
• Enhances fatty-acid utilisation without affecting glucose homeostasis
💪 No Muscle or Organ Growth Activity
• Lacks anabolic or growth-promoting effects of full hGH
📉 Body Composition Research
• Widely investigated in studies focused on fat reduction and metabolic balance
Human-Relevant Research Applications
🔬 Adipose tissue and metabolic regulation
AOD-9604 has been shown in human-relevant studies to stimulate lipolysis in adipose tissue while inhibiting lipogenesis, without impacting insulin-like growth factor-1 (IGF-1) levels. This makes it particularly useful in fat-loss and obesity-related research models.
Mechanism Overview
AOD-9604 selectively activates fat-specific metabolic pathways by:
-
Increasing breakdown of stored triglycerides
-
Reducing fat storage signalling
-
Supporting fatty-acid oxidation
Crucially, it does this without activating growth hormone pathways, allowing for targeted metabolic research.